SIRT1 and metabolic dysfunction-associated steatohepatitis: A study on the therapeutic effects of Naringenin on NASH [96] showed that Naringenin improves hepatic steatosis, hepatic fibrosis, hepatic inflammation, and hepatic oxidative stress in NASH mice, and it suggests that Naringenin exerts its therapeutic effects through SIRT1.